Viewing Study NCT01870505


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2026-04-08 @ 4:23 AM
Study NCT ID: NCT01870505
Status: COMPLETED
Last Update Posted: 2024-12-09
First Post: 2013-06-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: